Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
Authors:
Open Access
- 1 November 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 7 (11) , 1138-1146
Abstract
Hypertension is a leading modifiable risk factor for cardiovascular disease (CVD).1 Meta-analyses of randomized trials have shown that pharmacological blood pressure (BP) lowering reduces the risk of major cardiovascular events across the spectrum of initial BP.2,3 The Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive treatment, defined by a systolic BP (SBP) target less than 120 mm Hg, reduced the risk of incident CVD and all-cause mortality compared with treatment to an SBP target of less than 140 mm Hg.4 Similar results, in favor of a lower SBP target of 110 mm Hg to less than 130 mm Hg, were also recently observed for a composite cardiovascular outcome in the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial.5 However, both trials were stopped after a median follow-up of approximately 3.3 years. The longer-term effect of intensive treatment on cardiovascular and all-cause mortality after either trial (ie, the legacy effect)6 has not been evaluated.Keywords
This publication has 25 references indexed in Scilit:
- Concordance between administrative data and clinical review for mortality in the randomized on/off bypass follow-up study (ROOBY-FS)Journal of Cardiac Surgery, 2017
- Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and MortalityJAMA Cardiology, 2017
- Comparison of Expert Adjudicated Coronary Heart Disease and Cardiovascular Disease Mortality With the National Death Index: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) StudyJournal of the American Heart Association, 2017
- Characterizing Frailty Status in the Systolic Blood Pressure Intervention TrialThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2016
- The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)Clinical Trials, 2014
- Normative Values of Cognitive and Physical Function in Older Adults: Findings from The Irish Longitudinal Study on AgeingJournal of the American Geriatrics Society, 2013
- Analyzing Competing Risk Data Using theRtimeregPackageJournal of Statistical Software, 2011
- Flexible competing risks regression modeling and goodness-of-fitLifetime Data Analysis, 2008
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989